Note: This post is about the glycine-regulated chloride channel, not the glycine binding site on NMDA receptors
Might the glycine receptor have an allosteric binding site similar in function to the bezodiazepine site on GABAA?
Both receptors are ligand-gated chloride channels. They both serve in an inhibitory capacity in the CNS. They are both widely distributed. They are both pentamers. Their active sites both have endogenous ligands that don't do a hell of a lot by themselves.
It seems GABAA is the target of so many pharmaceuticals because Leo Sternbach (discoverer of benzodiazepines) got lucky and found the GABA molecule a buddy.
I take it we still don't know much about the glycine receptor, but suppose for a second that we found a way to dramatically increase its opening frequency, causing significant chloride influxes to the respective neurons and shunting the relevant pathways. (What might that feel like?)
A quick glance at known glycine receptor agonists leaves one underwhelmed. Wiki lists the amino acids alanine, dimethylglycine, glycine, hypotaurine, methylglycine, serine, taurine, trimethylglycine. One gets the sense that not much headway has been made toward designing high-efficacy glycine agonists.
But then one looks at one of the known antagonists of the glycine receptor: Pitrazepin:
It is also known that pitrazepine has affinity for the benzodiazepine site on GABAA (where it acts as a weak antagonist). And so--one surmises--it is also a negative allosteric modulator at the glycine receptor (i.e. it does not dock onto the same site as the glycine molecule).
One therefore ponders if there is a pharmacophore for positive allosteric modulation of the glycine receptor . . .
Thanx in advance for any info!
Might the glycine receptor have an allosteric binding site similar in function to the bezodiazepine site on GABAA?
Both receptors are ligand-gated chloride channels. They both serve in an inhibitory capacity in the CNS. They are both widely distributed. They are both pentamers. Their active sites both have endogenous ligands that don't do a hell of a lot by themselves.
It seems GABAA is the target of so many pharmaceuticals because Leo Sternbach (discoverer of benzodiazepines) got lucky and found the GABA molecule a buddy.
I take it we still don't know much about the glycine receptor, but suppose for a second that we found a way to dramatically increase its opening frequency, causing significant chloride influxes to the respective neurons and shunting the relevant pathways. (What might that feel like?)
A quick glance at known glycine receptor agonists leaves one underwhelmed. Wiki lists the amino acids alanine, dimethylglycine, glycine, hypotaurine, methylglycine, serine, taurine, trimethylglycine. One gets the sense that not much headway has been made toward designing high-efficacy glycine agonists.
But then one looks at one of the known antagonists of the glycine receptor: Pitrazepin:
It is also known that pitrazepine has affinity for the benzodiazepine site on GABAA (where it acts as a weak antagonist). And so--one surmises--it is also a negative allosteric modulator at the glycine receptor (i.e. it does not dock onto the same site as the glycine molecule).
One therefore ponders if there is a pharmacophore for positive allosteric modulation of the glycine receptor . . .
Thanx in advance for any info!
